EnviroTech :: Biotech
Lonza to Build Cell Therapy Production Facility in Singapore
12:19 AM MDT | May 19, 2009 | Deepti Ramesh
Lonza says it will build a new cell therapy manufacturing facility in Singapore to expand its global presence and to meet the growing worldwide demand for cell therapies. The facility will be located adjacent to Lonza’s large-scale mammalian manufacturing facility at Tuas Biomedical Park in Singapore. The first phase of the facility will involve an investment of SF30 million ($27 million). Construction of the facility will begin in early 2010 and it is expected to start manufacturing therapies in the first two suites by mid 2011. The facility will be...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee